Angiogenesis in two human prostate cancer cell lines with differing metastatic potential when growing as solid tumors in nude mice

Journal of Urology

Volumn 160, Issue 3 I, 1998, Pages 932-936

  Connolly, Jeanne M ^a   Rose, David P ^a  

^a AMERICAN HEALTH FOUNDATION   (United States)

Author keywords

Angiogenesis; Metastasis; Prostate cancer; Vascular endothelial growth factor

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER TRANSPLANTATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; METASTASIS POTENTIAL; MOUSE; NONHUMAN; NUDE MOUSE; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION;

EID: 0032323155     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)62835-0     Document Type: Article

References (41)

1. Folkman, J.: What is the evidence that tumors are angiogenesis dependent? J. Natl. Cancer Inst., 82: 4, 1990.
2. Weidner, N.: Tumor angiogenesis: review of current applications in tumor prognostication. Sem. Diag. Path., 10: 302, 1993.
3. Heimann, R., Ferguson, D., Powers, C., Recant, W. M., Weichselbaum, R. R. and Hellman, S.: Angiogenesis as a predictor of long-term survival for patients with node-negative breast cancer, J. Natl. Cancer Inst., 88: 1764, 1996.
4. Fox, S. B., Leek, R. D., Bliss, J., Mansi, J. L., Gusterson, B., Gatter, K. C. and Harris, A. L.: Association of tumor angiogenesis with bone marrow micrometastases in breast cancer patients. J. Natl. Cancer Inst., 89: 1044, 1997.
5. Wakui, S., Furusato, M., Itoh, T., Sasaki, H., Akiyama, A., Kinoshita, I., Tokuda, T., Aizawa, S. and Ushigome, S.: Tumor angiogenesis in prostatic carcinoma with and without bone marrow metastasis: a morphological study. J. Pathol., 168: 257, 1992.
6. Brawer, M. K., Deering, R. E., Brown, M., Preston, S. D. and Bigler, S. A.: Predictors of pathologic stage in prostatic carcinoma. The role of neovascularity. Cancer, 73: 678, 1994.
7. Furusato, M., Wakui, S., Sasaki, H., Ito, K. and Ushigome, S.: Tumor angiogenesis in latent prostatic carcinoma. Br. J. Cancer, 70: 1244, 1994.
8. Webber, M. M., Bello, D. and Quader, S.: Immortalized and tumorigenic adult human prostatic epithelial cell lines: characteristics and applications. II. Tumorigenic cell lines. Prostate, 30: 30, 58, 1997.
9. Albini, A., Iwamoto, Y., Kleinman, H. K., Martin, G. R., Aaronson, S. A., Kozlowski, J. M. and McEwan, R. N.: A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res., 47: 3239, 1987.
10. Hoosein, N. M., Boyd, D. D., Hollas, W. J., Maser, A., Henkin, J. and Chung, L. W. K.: Involvement of urokinase and its receptor in the invasiveness of human prostatic carcinoma cell lines. Cancer Commun., 3: 255, 1991.
11. Kozlowski, J. M., Fidler, I. J., Campbell, D., Xu, Z.-L., Kaighn, M. E. and Hart, I. R.: Metastatic behavior of human tumor cell lines grown in the nude mouse. Cancer Res., 44: 3522, 1984.
12. Connolly, J. M., Sun, X.-G. and Rose, D. P.: A comparison of the expression of the malignant phenotype in two androgen-independent human prostate cancer cell lines after orthotopic implantation in nude mice. Int. J. Oncol., 11: 771, 1997.
13. Thomas, K. A.: Vascular endothelial growth factor, a potent and selective angiogenic agent. J. Biol. Chem., 271: 603, 1996.
14. Slavin, J.: Fibroblast growth factors: at the heart of angiogenesis. Cell Biol. Int., 19: 431, 1995.
15. Roberts, A. B., Sporn, M. B., Assoian, R. K., Smith, J. M., Roche, N. S., Wakefield, L. M., Heine, U. I., Liotta, L. A., Falanga, V., Kehrl, J. H. and Fauci, A. S.: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc. Natl. Acad. Sci. USA, 83: 4167, 1986.
16. Yang, E. Y. and Moses, H. L.: Transforming growth factor β1-induced changes in cell migration, proliferation and angiogenesis in the chicken chorioallantoic membrane. J. Cell Biol., 111: 731, 1990.
17. Stephenson, R. A., Dinney, C. P. N., Gohji, K., Ordonez, N. G., Killion, J. J. and Fidler, I. J.: Metastatic model for human prostate cancer using orthotopic implantation in nude mice. J. Natl. Cancer Inst., 84: 951, 1992.
18. Weidner, N.: Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors. Breast Cancer Res. Treat., 36: 169, 1995.
19. Ferrara, N., Houck, K., Jakeman, L. and Leung, D. W.: Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocrine Rev., 13: 18, 1992.
20. Lissbrant, I. F., Stattin, P., Damber, J-E. and Bergh, A.: Vascular density is a predictor of cancer-specific survival in prostatic carcinoma. Prostate, 33: 38, 1997.
21. Toi, M., Hoshina, S., Takayanagi, T. and Tominaga, T.: Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer. Jpn. J. Cancer Res., 85: 1045, 1994.
22. Mattern, J., Koomägi, R. and Volm, M.: Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumour cell proliferation in human epidermoid lung carcinoma. Br. J. Cancer, 73: 931, 1996.
23. Houck, K. A., Leung, D. W., Rowland, A. M., Winer, J. and Ferrara, N.: Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J. Biol. Chem., 267: 26031, 1992.
24. Oshika, Y., Nakamura, M., Tokunaga, T., Ozeki, Y., Fukushima, Y., Hatanaka, H., Abe, Y., Yamazaki, H., Kijima, H., Tamaoki, N. and Ueyama, Y.: Expression of cell-associated isoform of vascular endothelial growth factor 189 and its prognostic relevance in non-small cell lung cancer. Int. J. Oncol., 12: 541, 1998.
25. Ferrer, F. A., Miller, L. J., Andrawis, R. I., Kurtzman, S. H., Albertsen, P. C., Laudone, V. P. and Kreutzer, D. L.: Vascular endothelial growth factor (VEGF) expression in human prostate cancer: in situ and in vitro expression of VEGF by human prostate cancer cells. J. Urol., 157: 2329, 1997.
26. Jackson, M. W., Bentel, J. M. and Tilley, W. D.: Vascular endothelial growth factor (VEGF) expression in prostate cancer and benign prostatic hyperplasia. J. Urol., 157: 2323, 1997.
27. Montesano, R., Vassalli, J-D., Baird, A., Guillemin, R. and Orci, L.: Basic fibroblast growth factor induces angiogenesis in vitro. Proc. Natl. Acad. Sci. USA, 83: 7297, 1986.
28. Odekon, L. E., Sato, Y. and Rifkin, D. B.: Urokinase-type plasminogen activator mediates basic fibroblast growth factor-induced bovine endothelial cell migration independent of its proteolytic activity. J. Cell Physiol., 150: 258, 1992.
29. Gagliardi, A., Hadd, H. and Collins, D. C.: Inhibition of angiogenesis by suramin. Cancer Res., 52: 5073, 1992.
30. Pesenti, E., Sola, F., Mongelli, N., Grandi, M. and Spreafico, F.: Suramin prevents neovascularization and tumour growth through blocking of basic fibroblast growth factor activity. Br. J. Cancer, 66: 367, 1992.
31. Takano, S., Gateley, S., Neville, M. E., Herblin, W. F., Gross, J. L., Engelhard, H., Perricone, M., Eidsvoog, K. and Brem, S.: Suramin, an anticancer and angiosuppressive agent, inhibits endothelial cell binding of basic fibroblast growth factor, migration, proliferation, and induction of urokinase-type plasminogen activator. Cancer Res., 54: 2654, 1994.
32. Ueki, N., Ohkawa, T., Yokoyama, Y., Maeda, J., Kawai, Y., Ikeda, T., Amuro, Y., Hada, T. and Higashino, K.: Potentiation of metastatic capacity by transforming growth factor-β1 gene transfection. Jpn. J. Cancer Res., 84: 589, 1993.
33. Relf, M., LeJeune, S., Scott, P. A. E., Fox, S., Smith, K., Leek, R., Moghaddam, A., Whitehouse, R., Bicknell, R. and Harris, A. L.: Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor β-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis. Cancer Res., 57: 963, 1997.
34. Pepper, M. S., Vassalli, J. D., Orci, L. and Montesano, R.: Biphasic effect of transforming growth factor-β1 on in vitro angiogenesis. Exp. Cell Res., 204: 356, 1993.
35. Roberts, A. B. and Sporn, M. B.: The transforming growth factor-betas. Handb. Exp. Pharmacol., 95: 419, 1990.
36. Hinck, A. P., Archer, S. J., Qian, S. W., Roberts, A. B., Sporn, M. B., Weatherbee, J. A., Tsang, M. L.-S., Lucas, R., Zhang, B.-L., Wenker, J. and Torchia, D. A.: Transforming growth factor β1: three-dimensional structure in solution and comparison with the X-ray structure of transforming growth factor β2. Biochemistry, 35: 8517, 1996.
37. Jennings, J. C., Mohan, S., Linkhart, T. A., Widstrom, R. and Baylink, D. J.: Comparison of the biological actions of TGF beta-1 and TGF beta-2: differential activity in endothelial cells. J. Cell Physiol., 137: 167, 1988.
38. 2 in vitro. Am. J. Path., 138: 37, 1991.
39. Madri, J. A., Bell, L. and Merwin, J. R.: Modulation of vascular cell behavior by transforming growth factors beta. Mol. Reprod. Dev., 32: 121, 1992.
40. Gorsch, S. M., Memoli, V. A., Stukel, T. A., Gold, L. I. and Arrick, B. A.: Immunohistochemical staining for transforming growth factor β1 associates with disease progression in human breast cancer. Cancer Res., 52: 6949, 1992.
41. Friedman, E., Gold, L. I., Klimstra, D., Zeng, Z.-S., Winawer, S. and Cohen, A.: High levels of transforming growth factor β1 correlate with disease progression in human colon cancer. Cancer Epidemiol. Biomarkers Prevent., 4: 549, 1995.